Global Oxytocin Receptor Antagonists Market Insights and Forecast to 2028

  • Report ID:226961
  • Industry Name: Chemical & Material
  • Publishing Date: Jun-22
  • No. of Pages: 98
                              
Oxytocin Receptor Antagonists market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Oxytocin Receptor Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Non-Peptide and Orally Active Oxytocin Receptor Antagonist High Affinity Human Oxytocin (OT) Receptor Antagonist Segment by Application Animals People By Company Ferring Sun Pharmaceutical Biopas PolyPeptide CS Bio Production by Region North America Europe China Japan Consumption by Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
                        
1 Study Coverage 1.1 Oxytocin Receptor Antagonists Product Introduction 1.2 Market by Type 1.2.1 Global Oxytocin Receptor Antagonists Market Size by Type, 2017 VS 2021 VS 2028 1.2.2 Non-Peptide and Orally Active Oxytocin Receptor Antagonist 1.2.3 High Affinity Human Oxytocin (OT) Receptor Antagonist 1.3 Market by Application 1.3.1 Global Oxytocin Receptor Antagonists Market Size by Application, 2017 VS 2021 VS 2028 1.3.2 Animals 1.3.3 People 1.4 Study Objectives 1.5 Years Considered 2 Global Oxytocin Receptor Antagonists Production 2.1 Global Oxytocin Receptor Antagonists Production Capacity (2017-2028) 2.2 Global Oxytocin Receptor Antagonists Production by Region: 2017 VS 2021 VS 2028 2.3 Global Oxytocin Receptor Antagonists Production by Region 2.3.1 Global Oxytocin Receptor Antagonists Historic Production by Region (2017-2022) 2.3.2 Global Oxytocin Receptor Antagonists Forecasted Production by Region (2023-2028) 2.4 North America 2.5 Europe 2.6 China 2.7 Japan 3 Global Oxytocin Receptor Antagonists Sales in Volume & Value Estimates and Forecasts 3.1 Global Oxytocin Receptor Antagonists Sales Estimates and Forecasts 2017-2028 3.2 Global Oxytocin Receptor Antagonists Revenue Estimates and Forecasts 2017-2028 3.3 Global Oxytocin Receptor Antagonists Revenue by Region: 2017 VS 2021 VS 2028 3.4 Global Oxytocin Receptor Antagonists Sales by Region 3.4.1 Global Oxytocin Receptor Antagonists Sales by Region (2017-2022) 3.4.2 Global Sales Oxytocin Receptor Antagonists by Region (2023-2028) 3.5 Global Oxytocin Receptor Antagonists Revenue by Region 3.5.1 Global Oxytocin Receptor Antagonists Revenue by Region (2017-2022) 3.5.2 Global Oxytocin Receptor Antagonists Revenue by Region (2023-2028) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Oxytocin Receptor Antagonists Production Capacity by Manufacturers 4.2 Global Oxytocin Receptor Antagonists Sales by Manufacturers 4.2.1 Global Oxytocin Receptor Antagonists Sales by Manufacturers (2017-2022) 4.2.2 Global Oxytocin Receptor Antagonists Sales Market Share by Manufacturers (2017-2022) 4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Oxytocin Receptor Antagonists in 2021 4.3 Global Oxytocin Receptor Antagonists Revenue by Manufacturers 4.3.1 Global Oxytocin Receptor Antagonists Revenue by Manufacturers (2017-2022) 4.3.2 Global Oxytocin Receptor Antagonists Revenue Market Share by Manufacturers (2017-2022) 4.3.3 Global Top 10 and Top 5 Companies by Oxytocin Receptor Antagonists Revenue in 2021 4.4 Global Oxytocin Receptor Antagonists Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Oxytocin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Oxytocin Receptor Antagonists Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Oxytocin Receptor Antagonists Sales by Type 5.1.1 Global Oxytocin Receptor Antagonists Historical Sales by Type (2017-2022) 5.1.2 Global Oxytocin Receptor Antagonists Forecasted Sales by Type (2023-2028) 5.1.3 Global Oxytocin Receptor Antagonists Sales Market Share by Type (2017-2028) 5.2 Global Oxytocin Receptor Antagonists Revenue by Type 5.2.1 Global Oxytocin Receptor Antagonists Historical Revenue by Type (2017-2022) 5.2.2 Global Oxytocin Receptor Antagonists Forecasted Revenue by Type (2023-2028) 5.2.3 Global Oxytocin Receptor Antagonists Revenue Market Share by Type (2017-2028) 5.3 Global Oxytocin Receptor Antagonists Price by Type 5.3.1 Global Oxytocin Receptor Antagonists Price by Type (2017-2022) 5.3.2 Global Oxytocin Receptor Antagonists Price Forecast by Type (2023-2028) 6 Market Size by Application 6.1 Global Oxytocin Receptor Antagonists Sales by Application 6.1.1 Global Oxytocin Receptor Antagonists Historical Sales by Application (2017-2022) 6.1.2 Global Oxytocin Receptor Antagonists Forecasted Sales by Application (2023-2028) 6.1.3 Global Oxytocin Receptor Antagonists Sales Market Share by Application (2017-2028) 6.2 Global Oxytocin Receptor Antagonists Revenue by Application 6.2.1 Global Oxytocin Receptor Antagonists Historical Revenue by Application (2017-2022) 6.2.2 Global Oxytocin Receptor Antagonists Forecasted Revenue by Application (2023-2028) 6.2.3 Global Oxytocin Receptor Antagonists Revenue Market Share by Application (2017-2028) 6.3 Global Oxytocin Receptor Antagonists Price by Application 6.3.1 Global Oxytocin Receptor Antagonists Price by Application (2017-2022) 6.3.2 Global Oxytocin Receptor Antagonists Price Forecast by Application (2023-2028) 7 North America 7.1 North America Oxytocin Receptor Antagonists Market Size by Type 7.1.1 North America Oxytocin Receptor Antagonists Sales by Type (2017-2028) 7.1.2 North America Oxytocin Receptor Antagonists Revenue by Type (2017-2028) 7.2 North America Oxytocin Receptor Antagonists Market Size by Application 7.2.1 North America Oxytocin Receptor Antagonists Sales by Application (2017-2028) 7.2.2 North America Oxytocin Receptor Antagonists Revenue by Application (2017-2028) 7.3 North America Oxytocin Receptor Antagonists Sales by Country 7.3.1 North America Oxytocin Receptor Antagonists Sales by Country (2017-2028) 7.3.2 North America Oxytocin Receptor Antagonists Revenue by Country (2017-2028) 7.3.3 U.S. 7.3.4 Canada 8 Europe 8.1 Europe Oxytocin Receptor Antagonists Market Size by Type 8.1.1 Europe Oxytocin Receptor Antagonists Sales by Type (2017-2028) 8.1.2 Europe Oxytocin Receptor Antagonists Revenue by Type (2017-2028) 8.2 Europe Oxytocin Receptor Antagonists Market Size by Application 8.2.1 Europe Oxytocin Receptor Antagonists Sales by Application (2017-2028) 8.2.2 Europe Oxytocin Receptor Antagonists Revenue by Application (2017-2028) 8.3 Europe Oxytocin Receptor Antagonists Sales by Country 8.3.1 Europe Oxytocin Receptor Antagonists Sales by Country (2017-2028) 8.3.2 Europe Oxytocin Receptor Antagonists Revenue by Country (2017-2028) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Oxytocin Receptor Antagonists Market Size by Type 9.1.1 Asia Pacific Oxytocin Receptor Antagonists Sales by Type (2017-2028) 9.1.2 Asia Pacific Oxytocin Receptor Antagonists Revenue by Type (2017-2028) 9.2 Asia Pacific Oxytocin Receptor Antagonists Market Size by Application 9.2.1 Asia Pacific Oxytocin Receptor Antagonists Sales by Application (2017-2028) 9.2.2 Asia Pacific Oxytocin Receptor Antagonists Revenue by Application (2017-2028) 9.3 Asia Pacific Oxytocin Receptor Antagonists Sales by Region 9.3.1 Asia Pacific Oxytocin Receptor Antagonists Sales by Region (2017-2028) 9.3.2 Asia Pacific Oxytocin Receptor Antagonists Revenue by Region (2017-2028) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 9.3.12 Philippines 10 Latin America 10.1 Latin America Oxytocin Receptor Antagonists Market Size by Type 10.1.1 Latin America Oxytocin Receptor Antagonists Sales by Type (2017-2028) 10.1.2 Latin America Oxytocin Receptor Antagonists Revenue by Type (2017-2028) 10.2 Latin America Oxytocin Receptor Antagonists Market Size by Application 10.2.1 Latin America Oxytocin Receptor Antagonists Sales by Application (2017-2028) 10.2.2 Latin America Oxytocin Receptor Antagonists Revenue by Application (2017-2028) 10.3 Latin America Oxytocin Receptor Antagonists Sales by Country 10.3.1 Latin America Oxytocin Receptor Antagonists Sales by Country (2017-2028) 10.3.2 Latin America Oxytocin Receptor Antagonists Revenue by Country (2017-2028) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Oxytocin Receptor Antagonists Market Size by Type 11.1.1 Middle East and Africa Oxytocin Receptor Antagonists Sales by Type (2017-2028) 11.1.2 Middle East and Africa Oxytocin Receptor Antagonists Revenue by Type (2017-2028) 11.2 Middle East and Africa Oxytocin Receptor Antagonists Market Size by Application 11.2.1 Middle East and Africa Oxytocin Receptor Antagonists Sales by Application (2017-2028) 11.2.2 Middle East and Africa Oxytocin Receptor Antagonists Revenue by Application (2017-2028) 11.3 Middle East and Africa Oxytocin Receptor Antagonists Sales by Country 11.3.1 Middle East and Africa Oxytocin Receptor Antagonists Sales by Country (2017-2028) 11.3.2 Middle East and Africa Oxytocin Receptor Antagonists Revenue by Country (2017-2028) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Ferring 12.1.1 Ferring Corporation Information 12.1.2 Ferring Overview 12.1.3 Ferring Oxytocin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2017-2022) 12.1.4 Ferring Oxytocin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications 12.1.5 Ferring Recent Developments 12.2 Sun Pharmaceutical 12.2.1 Sun Pharmaceutical Corporation Information 12.2.2 Sun Pharmaceutical Overview 12.2.3 Sun Pharmaceutical Oxytocin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2017-2022) 12.2.4 Sun Pharmaceutical Oxytocin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications 12.2.5 Sun Pharmaceutical Recent Developments 12.3 Biopas 12.3.1 Biopas Corporation Information 12.3.2 Biopas Overview 12.3.3 Biopas Oxytocin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2017-2022) 12.3.4 Biopas Oxytocin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications 12.3.5 Biopas Recent Developments 12.4 PolyPeptide 12.4.1 PolyPeptide Corporation Information 12.4.2 PolyPeptide Overview 12.4.3 PolyPeptide Oxytocin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2017-2022) 12.4.4 PolyPeptide Oxytocin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications 12.4.5 PolyPeptide Recent Developments 12.5 CS Bio 12.5.1 CS Bio Corporation Information 12.5.2 CS Bio Overview 12.5.3 CS Bio Oxytocin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2017-2022) 12.5.4 CS Bio Oxytocin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications 12.5.5 CS Bio Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Oxytocin Receptor Antagonists Industry Chain Analysis 13.2 Oxytocin Receptor Antagonists Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Oxytocin Receptor Antagonists Production Mode & Process 13.4 Oxytocin Receptor Antagonists Sales and Marketing 13.4.1 Oxytocin Receptor Antagonists Sales Channels 13.4.2 Oxytocin Receptor Antagonists Distributors 13.5 Oxytocin Receptor Antagonists Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Oxytocin Receptor Antagonists Industry Trends 14.2 Oxytocin Receptor Antagonists Market Drivers 14.3 Oxytocin Receptor Antagonists Market Challenges 14.4 Oxytocin Receptor Antagonists Market Restraints 15 Key Finding in The Global Oxytocin Receptor Antagonists Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
                
List of Tables Table 1. Global Oxytocin Receptor Antagonists Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Non-Peptide and Orally Active Oxytocin Receptor Antagonist Table 3. Major Manufacturers of High Affinity Human Oxytocin (OT) Receptor Antagonist Table 4. Global Oxytocin Receptor Antagonists Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million) Table 5. Global Oxytocin Receptor Antagonists Production by Region: 2017 VS 2021 VS 2028 (Kiloton) Table 6. Global Oxytocin Receptor Antagonists Production by Region (2017-2022) & (Kiloton) Table 7. Global Oxytocin Receptor Antagonists Production Market Share by Region (2017-2022) Table 8. Global Oxytocin Receptor Antagonists Production by Region (2023-2028) & (Kiloton) Table 9. Global Oxytocin Receptor Antagonists Production Market Share by Region (2023-2028) Table 10. Global Oxytocin Receptor Antagonists Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 11. Global Oxytocin Receptor Antagonists Sales by Region (2017-2022) & (Kiloton) Table 12. Global Oxytocin Receptor Antagonists Sales Market Share by Region (2017-2022) Table 13. Global Oxytocin Receptor Antagonists Sales by Region (2023-2028) & (Kiloton) Table 14. Global Oxytocin Receptor Antagonists Sales Market Share by Region (2023-2028) Table 15. Global Oxytocin Receptor Antagonists Revenue by Region (2017-2022) & (US$ Million) Table 16. Global Oxytocin Receptor Antagonists Revenue Market Share by Region (2017-2022) Table 17. Global Oxytocin Receptor Antagonists Revenue by Region (2023-2028) & (US$ Million) Table 18. Global Oxytocin Receptor Antagonists Revenue Market Share by Region (2023-2028) Table 19. Global Oxytocin Receptor Antagonists Production Capacity by Manufacturers (2017-2022) & (Kiloton) Table 20. Global Oxytocin Receptor Antagonists Capacity Market Share by Manufacturers (2017-2022) Table 21. Global Oxytocin Receptor Antagonists Sales by Manufacturers (2017-2022) & (Kiloton) Table 22. Global Oxytocin Receptor Antagonists Sales Market Share by Manufacturers (2017-2022) Table 23. Global Oxytocin Receptor Antagonists Revenue by Manufacturers (2017-2022) & (US$ Million) Table 24. Global Oxytocin Receptor Antagonists Revenue Share by Manufacturers (2017-2022) Table 25. Oxytocin Receptor Antagonists Price by Manufacturers 2017-2022 (US$/Ton) Table 26. Global Oxytocin Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI) Table 27. Global Oxytocin Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxytocin Receptor Antagonists as of 2021) Table 28. Oxytocin Receptor Antagonists Manufacturing Base Distribution and Headquarters Table 29. Manufacturers Oxytocin Receptor Antagonists Product Offered Table 30. Date of Manufacturers Enter into Oxytocin Receptor Antagonists Market Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Oxytocin Receptor Antagonists Sales by Type (2017-2022) & (Kiloton) Table 33. Global Oxytocin Receptor Antagonists Sales by Type (2023-2028) & (Kiloton) Table 34. Global Oxytocin Receptor Antagonists Sales Share by Type (2017-2022) Table 35. Global Oxytocin Receptor Antagonists Sales Share by Type (2023-2028) Table 36. Global Oxytocin Receptor Antagonists Revenue by Type (2017-2022) & (US$ Million) Table 37. Global Oxytocin Receptor Antagonists Revenue by Type (2023-2028) & (US$ Million) Table 38. Global Oxytocin Receptor Antagonists Revenue Share by Type (2017-2022) Table 39. Global Oxytocin Receptor Antagonists Revenue Share by Type (2023-2028) Table 40. Oxytocin Receptor Antagonists Price by Type (2017-2022) & (US$/Ton) Table 41. Global Oxytocin Receptor Antagonists Price Forecast by Type (2023-2028) & (US$/Ton) Table 42. Global Oxytocin Receptor Antagonists Sales by Application (2017-2022) & (Kiloton) Table 43. Global Oxytocin Receptor Antagonists Sales by Application (2023-2028) & (Kiloton) Table 44. Global Oxytocin Receptor Antagonists Sales Share by Application (2017-2022) Table 45. Global Oxytocin Receptor Antagonists Sales Share by Application (2023-2028) Table 46. Global Oxytocin Receptor Antagonists Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Oxytocin Receptor Antagonists Revenue by Application (2023-2028) & (US$ Million) Table 48. Global Oxytocin Receptor Antagonists Revenue Share by Application (2017-2022) Table 49. Global Oxytocin Receptor Antagonists Revenue Share by Application (2023-2028) Table 50. Oxytocin Receptor Antagonists Price by Application (2017-2022) & (US$/Ton) Table 51. Global Oxytocin Receptor Antagonists Price Forecast by Application (2023-2028) & (US$/Ton) Table 52. North America Oxytocin Receptor Antagonists Sales by Type (2017-2022) & (Kiloton) Table 53. North America Oxytocin Receptor Antagonists Sales by Type (2023-2028) & (Kiloton) Table 54. North America Oxytocin Receptor Antagonists Revenue by Type (2017-2022) & (US$ Million) Table 55. North America Oxytocin Receptor Antagonists Revenue by Type (2023-2028) & (US$ Million) Table 56. North America Oxytocin Receptor Antagonists Sales by Application (2017-2022) & (Kiloton) Table 57. North America Oxytocin Receptor Antagonists Sales by Application (2023-2028) & (Kiloton) Table 58. North America Oxytocin Receptor Antagonists Revenue by Application (2017-2022) & (US$ Million) Table 59. North America Oxytocin Receptor Antagonists Revenue by Application (2023-2028) & (US$ Million) Table 60. North America Oxytocin Receptor Antagonists Sales by Country (2017-2022) & (Kiloton) Table 61. North America Oxytocin Receptor Antagonists Sales by Country (2023-2028) & (Kiloton) Table 62. North America Oxytocin Receptor Antagonists Revenue by Country (2017-2022) & (US$ Million) Table 63. North America Oxytocin Receptor Antagonists Revenue by Country (2023-2028) & (US$ Million) Table 64. Europe Oxytocin Receptor Antagonists Sales by Type (2017-2022) & (Kiloton) Table 65. Europe Oxytocin Receptor Antagonists Sales by Type (2023-2028) & (Kiloton) Table 66. Europe Oxytocin Receptor Antagonists Revenue by Type (2017-2022) & (US$ Million) Table 67. Europe Oxytocin Receptor Antagonists Revenue by Type (2023-2028) & (US$ Million) Table 68. Europe Oxytocin Receptor Antagonists Sales by Application (2017-2022) & (Kiloton) Table 69. Europe Oxytocin Receptor Antagonists Sales by Application (2023-2028) & (Kiloton) Table 70. Europe Oxytocin Receptor Antagonists Revenue by Application (2017-2022) & (US$ Million) Table 71. Europe Oxytocin Receptor Antagonists Revenue by Application (2023-2028) & (US$ Million) Table 72. Europe Oxytocin Receptor Antagonists Sales by Country (2017-2022) & (Kiloton) Table 73. Europe Oxytocin Receptor Antagonists Sales by Country (2023-2028) & (Kiloton) Table 74. Europe Oxytocin Receptor Antagonists Revenue by Country (2017-2022) & (US$ Million) Table 75. Europe Oxytocin Receptor Antagonists Revenue by Country (2023-2028) & (US$ Million) Table 76. Asia Pacific Oxytocin Receptor Antagonists Sales by Type (2017-2022) & (Kiloton) Table 77. Asia Pacific Oxytocin Receptor Antagonists Sales by Type (2023-2028) & (Kiloton) Table 78. Asia Pacific Oxytocin Receptor Antagonists Revenue by Type (2017-2022) & (US$ Million) Table 79. Asia Pacific Oxytocin Receptor Antagonists Revenue by Type (2023-2028) & (US$ Million) Table 80. Asia Pacific Oxytocin Receptor Antagonists Sales by Application (2017-2022) & (Kiloton) Table 81. Asia Pacific Oxytocin Receptor Antagonists Sales by Application (2023-2028) & (Kiloton) Table 82. Asia Pacific Oxytocin Receptor Antagonists Revenue by Application (2017-2022) & (US$ Million) Table 83. Asia Pacific Oxytocin Receptor Antagonists Revenue by Application (2023-2028) & (US$ Million) Table 84. Asia Pacific Oxytocin Receptor Antagonists Sales by Region (2017-2022) & (Kiloton) Table 85. Asia Pacific Oxytocin Receptor Antagonists Sales by Region (2023-2028) & (Kiloton) Table 86. Asia Pacific Oxytocin Receptor Antagonists Revenue by Region (2017-2022) & (US$ Million) Table 87. Asia Pacific Oxytocin Receptor Antagonists Revenue by Region (2023-2028) & (US$ Million) Table 88. Latin America Oxytocin Receptor Antagonists Sales by Type (2017-2022) & (Kiloton) Table 89. Latin America Oxytocin Receptor Antagonists Sales by Type (2023-2028) & (Kiloton) Table 90. Latin America Oxytocin Receptor Antagonists Revenue by Type (2017-2022) & (US$ Million) Table 91. Latin America Oxytocin Receptor Antagonists Revenue by Type (2023-2028) & (US$ Million) Table 92. Latin America Oxytocin Receptor Antagonists Sales by Application (2017-2022) & (Kiloton) Table 93. Latin America Oxytocin Receptor Antagonists Sales by Application (2023-2028) & (Kiloton) Table 94. Latin America Oxytocin Receptor Antagonists Revenue by Application (2017-2022) & (US$ Million) Table 95. Latin America Oxytocin Receptor Antagonists Revenue by Application (2023-2028) & (US$ Million) Table 96. Latin America Oxytocin Receptor Antagonists Sales by Country (2017-2022) & (Kiloton) Table 97. Latin America Oxytocin Receptor Antagonists Sales by Country (2023-2028) & (Kiloton) Table 98. Latin America Oxytocin Receptor Antagonists Revenue by Country (2017-2022) & (US$ Million) Table 99. Latin America Oxytocin Receptor Antagonists Revenue by Country (2023-2028) & (US$ Million) Table 100. Middle East and Africa Oxytocin Receptor Antagonists Sales by Type (2017-2022) & (Kiloton) Table 101. Middle East and Africa Oxytocin Receptor Antagonists Sales by Type (2023-2028) & (Kiloton) Table 102. Middle East and Africa Oxytocin Receptor Antagonists Revenue by Type (2017-2022) & (US$ Million) Table 103. Middle East and Africa Oxytocin Receptor Antagonists Revenue by Type (2023-2028) & (US$ Million) Table 104. Middle East and Africa Oxytocin Receptor Antagonists Sales by Application (2017-2022) & (Kiloton) Table 105. Middle East and Africa Oxytocin Receptor Antagonists Sales by Application (2023-2028) & (Kiloton) Table 106. Middle East and Africa Oxytocin Receptor Antagonists Revenue by Application (2017-2022) & (US$ Million) Table 107. Middle East and Africa Oxytocin Receptor Antagonists Revenue by Application (2023-2028) & (US$ Million) Table 108. Middle East and Africa Oxytocin Receptor Antagonists Sales by Country (2017-2022) & (Kiloton) Table 109. Middle East and Africa Oxytocin Receptor Antagonists Sales by Country (2023-2028) & (Kiloton) Table 110. Middle East and Africa Oxytocin Receptor Antagonists Revenue by Country (2017-2022) & (US$ Million) Table 111. Middle East and Africa Oxytocin Receptor Antagonists Revenue by Country (2023-2028) & (US$ Million) Table 112. Ferring Corporation Information Table 113. Ferring Description and Major Businesses Table 114. Ferring Oxytocin Receptor Antagonists Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 115. Ferring Oxytocin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications Table 116. Ferring Recent Development Table 117. Sun Pharmaceutical Corporation Information Table 118. Sun Pharmaceutical Description and Major Businesses Table 119. Sun Pharmaceutical Oxytocin Receptor Antagonists Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 120. Sun Pharmaceutical Oxytocin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications Table 121. Sun Pharmaceutical Recent Development Table 122. Biopas Corporation Information Table 123. Biopas Description and Major Businesses Table 124. Biopas Oxytocin Receptor Antagonists Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 125. Biopas Oxytocin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications Table 126. Biopas Recent Development Table 127. PolyPeptide Corporation Information Table 128. PolyPeptide Description and Major Businesses Table 129. PolyPeptide Oxytocin Receptor Antagonists Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 130. PolyPeptide Oxytocin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications Table 131. PolyPeptide Recent Development Table 132. CS Bio Corporation Information Table 133. CS Bio Description and Major Businesses Table 134. CS Bio Oxytocin Receptor Antagonists Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 135. CS Bio Oxytocin Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications Table 136. CS Bio Recent Development Table 137. Key Raw Materials Lists Table 138. Raw Materials Key Suppliers Lists Table 139. Oxytocin Receptor Antagonists Distributors List Table 140. Oxytocin Receptor Antagonists Customers List Table 141. Oxytocin Receptor Antagonists Market Trends Table 142. Oxytocin Receptor Antagonists Market Drivers Table 143. Oxytocin Receptor Antagonists Market Challenges Table 144. Oxytocin Receptor Antagonists Market Restraints Table 145. Research Programs/Design for This Report Table 146. Key Data Information from Secondary Sources Table 147. Key Data Information from Primary Sources List of Figures Figure 1. Oxytocin Receptor Antagonists Product Picture Figure 2. Global Oxytocin Receptor Antagonists Market Share by Type in 2021 & 2028 Figure 3. Non-Peptide and Orally Active Oxytocin Receptor Antagonist Product Picture Figure 4. High Affinity Human Oxytocin (OT) Receptor Antagonist Product Picture Figure 5. Global Oxytocin Receptor Antagonists Market Share by Application in 2021 & 2028 Figure 6. Animals Figure 7. People Figure 8. Oxytocin Receptor Antagonists Report Years Considered Figure 9. Global Oxytocin Receptor Antagonists Capacity, Production and Utilization (2017-2028) & (Kiloton) Figure 10. Global Oxytocin Receptor Antagonists Production Market Share by Region in Percentage: 2021 Versus 2028 Figure 11. Global Oxytocin Receptor Antagonists Production Market Share by Region (2017-2022) Figure 12. Global Oxytocin Receptor Antagonists Production Market Share by Region (2023-2028) Figure 13. Oxytocin Receptor Antagonists Production Growth Rate in North America (2017-2028) & (Kiloton) Figure 14. Oxytocin Receptor Antagonists Production Growth Rate in Europe (2017-2028) & (Kiloton) Figure 15. Oxytocin Receptor Antagonists Production Growth Rate in China (2017-2028) & (Kiloton) Figure 16. Oxytocin Receptor Antagonists Production Growth Rate in Japan (2017-2028) & (Kiloton) Figure 17. Global Oxytocin Receptor Antagonists Sales 2017-2028 (Kiloton) Figure 18. Global Oxytocin Receptor Antagonists Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 19. Global Oxytocin Receptor Antagonists Revenue 2017-2028 (US$ Million) Figure 20. Global Oxytocin Receptor Antagonists Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 21. Global Oxytocin Receptor Antagonists Sales Market Share by Region (2017-2022) Figure 22. Global Oxytocin Receptor Antagonists Sales Market Share by Region (2023-2028) Figure 23. North America Oxytocin Receptor Antagonists Sales YoY (2017-2028) & (Kiloton) Figure 24. North America Oxytocin Receptor Antagonists Revenue YoY (2017-2028) & (US$ Million) Figure 25. Europe Oxytocin Receptor Antagonists Sales YoY (2017-2028) & (Kiloton) Figure 26. Europe Oxytocin Receptor Antagonists Revenue YoY (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Oxytocin Receptor Antagonists Sales YoY (2017-2028) & (Kiloton) Figure 28. Asia-Pacific Oxytocin Receptor Antagonists Revenue YoY (2017-2028) & (US$ Million) Figure 29. Latin America Oxytocin Receptor Antagonists Sales YoY (2017-2028) & (Kiloton) Figure 30. Latin America Oxytocin Receptor Antagonists Revenue YoY (2017-2028) & (US$ Million) Figure 31. Middle East & Africa Oxytocin Receptor Antagonists Sales YoY (2017-2028) & (Kiloton) Figure 32. Middle East & Africa Oxytocin Receptor Antagonists Revenue YoY (2017-2028) & (US$ Million) Figure 33. The Oxytocin Receptor Antagonists Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 34. The Top 5 and 10 Largest Manufacturers of Oxytocin Receptor Antagonists in the World: Market Share by Oxytocin Receptor Antagonists Revenue in 2021 Figure 35. Oxytocin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 36. Global Oxytocin Receptor Antagonists Sales Market Share by Type (2017-2028) Figure 37. Global Oxytocin Receptor Antagonists Revenue Market Share by Type (2017-2028) Figure 38. Global Oxytocin Receptor Antagonists Sales Market Share by Application (2017-2028) Figure 39. Global Oxytocin Receptor Antagonists Revenue Market Share by Application (2017-2028) Figure 40. North America Oxytocin Receptor Antagonists Sales Market Share by Type (2017-2028) Figure 41. North America Oxytocin Receptor Antagonists Revenue Market Share by Type (2017-2028) Figure 42. North America Oxytocin Receptor Antagonists Sales Market Share by Application (2017-2028) Figure 43. North America Oxytocin Receptor Antagonists Revenue Market Share by Application (2017-2028) Figure 44. North America Oxytocin Receptor Antagonists Sales Share by Country (2017-2028) Figure 45. North America Oxytocin Receptor Antagonists Revenue Share by Country (2017-2028) Figure 46. U.S. Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 47. Canada Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 48. Europe Oxytocin Receptor Antagonists Sales Market Share by Type (2017-2028) Figure 49. Europe Oxytocin Receptor Antagonists Revenue Market Share by Type (2017-2028) Figure 50. Europe Oxytocin Receptor Antagonists Sales Market Share by Application (2017-2028) Figure 51. Europe Oxytocin Receptor Antagonists Revenue Market Share by Application (2017-2028) Figure 52. Europe Oxytocin Receptor Antagonists Sales Share by Country (2017-2028) Figure 53. Europe Oxytocin Receptor Antagonists Revenue Share by Country (2017-2028) Figure 54. Germany Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 55. France Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 56. U.K. Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 57. Italy Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 58. Russia Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 59. Asia Pacific Oxytocin Receptor Antagonists Sales Market Share by Type (2017-2028) Figure 60. Asia Pacific Oxytocin Receptor Antagonists Revenue Market Share by Type (2017-2028) Figure 61. Asia Pacific Oxytocin Receptor Antagonists Sales Market Share by Application (2017-2028) Figure 62. Asia Pacific Oxytocin Receptor Antagonists Revenue Market Share by Application (2017-2028) Figure 63. Asia Pacific Oxytocin Receptor Antagonists Sales Share by Region (2017-2028) Figure 64. Asia Pacific Oxytocin Receptor Antagonists Revenue Share by Region (2017-2028) Figure 65. China Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 66. Japan Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 67. South Korea Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 68. India Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 69. Australia Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 70. Taiwan Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 71. Indonesia Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 72. Thailand Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 73. Malaysia Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 74. Philippines Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 75. Latin America Oxytocin Receptor Antagonists Sales Market Share by Type (2017-2028) Figure 76. Latin America Oxytocin Receptor Antagonists Revenue Market Share by Type (2017-2028) Figure 77. Latin America Oxytocin Receptor Antagonists Sales Market Share by Application (2017-2028) Figure 78. Latin America Oxytocin Receptor Antagonists Revenue Market Share by Application (2017-2028) Figure 79. Latin America Oxytocin Receptor Antagonists Sales Share by Country (2017-2028) Figure 80. Latin America Oxytocin Receptor Antagonists Revenue Share by Country (2017-2028) Figure 81. Mexico Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 82. Brazil Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 83. Argentina Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 84. Middle East and Africa Oxytocin Receptor Antagonists Sales Market Share by Type (2017-2028) Figure 85. Middle East and Africa Oxytocin Receptor Antagonists Revenue Market Share by Type (2017-2028) Figure 86. Middle East and Africa Oxytocin Receptor Antagonists Sales Market Share by Application (2017-2028) Figure 87. Middle East and Africa Oxytocin Receptor Antagonists Revenue Market Share by Application (2017-2028) Figure 88. Middle East and Africa Oxytocin Receptor Antagonists Sales Share by Country (2017-2028) Figure 89. Middle East and Africa Oxytocin Receptor Antagonists Revenue Share by Country (2017-2028) Figure 90. Turkey Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 91. Saudi Arabia Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 92. UAE Oxytocin Receptor Antagonists Revenue (2017-2028) & (US$ Million) Figure 93. Oxytocin Receptor Antagonists Value Chain Figure 94. Oxytocin Receptor Antagonists Production Process Figure 95. Channels of Distribution Figure 96. Distributors Profiles Figure 97. Bottom-up and Top-down Approaches for This Report Figure 98. Data Triangulation Figure 99. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.